U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C12H17N
Molecular Weight 175.2705
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of 1-PHENYLCYCLOHEXYLAMINE

SMILES

c1ccc(cc1)C2(CCCCC2)N

InChI

InChIKey=RGZGRPPQZUQUCR-UHFFFAOYSA-N
InChI=1S/C12H17N/c13-12(9-5-2-6-10-12)11-7-3-1-4-8-11/h1,3-4,7-8H,2,5-6,9-10,13H2

HIDE SMILES / InChI

Molecular Formula C12H17N
Molecular Weight 175.2705
Charge 0
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Approval Year

Targets

Targets

Primary TargetPharmacologyConditionPotency
Target ID: NMDA receptor-coupled channels
PubMed

PubMed

TitleDatePubMed
The ability of new non-competitive glutamate receptor blockers to weaken motor disorders in animals.
2003 Mar
[Effects of blockade of ionotropic glutamate receptors on the development of pentylenetetrazole kindling in mice].
2005 Nov
Effects of ionotropic glutamate receptor channel blockers on the development of pentylenetetrazol kindling in mice.
2007 Jan
Substance Class Chemical
Created
by admin
on Sat Jun 26 04:14:09 UTC 2021
Edited
by admin
on Sat Jun 26 04:14:09 UTC 2021
Record UNII
HBO2D49I2S
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
1-PHENYLCYCLOHEXYLAMINE
Systematic Name English
CYCLOHEXANAMINE, 1-PHENYL-
Systematic Name English
1-PHENYLCYCLOHEXYLAMINE (PRECURSORS TO PHENCYCLIDINE (PCP))
Common Name English
Classification Tree Code System Code
DEA NO. 7460
Created by admin on Sat Jun 26 04:14:09 UTC 2021 , Edited by admin on Sat Jun 26 04:14:09 UTC 2021
Code System Code Type Description
EPA CompTox
2201-24-3
Created by admin on Sat Jun 26 04:14:09 UTC 2021 , Edited by admin on Sat Jun 26 04:14:09 UTC 2021
PRIMARY
PUBCHEM
31862
Created by admin on Sat Jun 26 04:14:09 UTC 2021 , Edited by admin on Sat Jun 26 04:14:09 UTC 2021
PRIMARY
CAS
2201-24-3
Created by admin on Sat Jun 26 04:14:09 UTC 2021 , Edited by admin on Sat Jun 26 04:14:09 UTC 2021
PRIMARY
FDA UNII
HBO2D49I2S
Created by admin on Sat Jun 26 04:14:09 UTC 2021 , Edited by admin on Sat Jun 26 04:14:09 UTC 2021
PRIMARY
DRUG BANK
DB01506
Created by admin on Sat Jun 26 04:14:09 UTC 2021 , Edited by admin on Sat Jun 26 04:14:09 UTC 2021
PRIMARY
Related Record Type Details
SALT/SOLVATE -> PARENT
Related Record Type Details
PARENT -> METABOLITE
This metabolite was detected in rat urine. However, according to this journal acticle, “The authors' experience in metabolism and analytical studies on rats and humans support the assumption that the metabolites found in rat urine should also be present in human urine. Therefore, it can be concluded that the procedure described here should also be applicable for human urine screening for PCEEA and/or PCMEA in clinical or forensic cases. However, their differentiation would only be possible through detection of the respective parent drug or unique metabolites.”
URINE
PARENT -> METABOLITE
This metabolite was detected in rat urine. However, according to this journal acticle, “The authors' experience in metabolism and analytical studies on rats and humans support the assumption that the metabolites found in rat urine should also be present in human urine. Therefore, it can be concluded that the procedure described here should also be applicable for human urine screening for PCEEA and/or PCMEA in clinical or forensic cases. However, their differentiation would only be possible through detection of the respective parent drug or unique metabolites.”
URINE
Related Record Type Details
ACTIVE MOIETY